Skip to main content

Regenerative Potential of Blood Stem Cell Products Used in Hematopoietic Stem Cell Transplantation

  • Chapter
  • First Online:
  • 854 Accesses

Part of the book series: Stem Cell Biology and Regenerative Medicine ((STEMCELL))

Abstract

In this chapter, we address the role of nonhematopoietic progenitors with regenerative potential that are present in blood stem cell grafts used in hematopoietic transplantation. In particular, we discuss the potential role of nonhematopoietic progenitors in reducing transplant-associated tissue toxicity. We discuss specific cell types including endothelial progenitors and mesenchymal stromal cells that may be associated with tissue repair, and we discuss some potential strategies for augmenting the regenerative capacity of blood stem cell products which could have more widespread applicability to a broad range of acute tissue injuries.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Abou-Nassar K, Li Y-C, Doucette S, Tinmouth A, McIntyre L, Allan DS (2009) The effect of allogeneic red blood cell transfusion on circulating vascular progenitor cells in critically ill patients. Transfusion Med 19:278–302

    Article  Google Scholar 

  • Aicher A, Heeschen C, Midner-Rihm C et al (2003) Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nature Med 9:1370–1376

    Article  PubMed  CAS  Google Scholar 

  • Aicher A, Zeiher AM, Dimmeler S (2005) Mobilizing endothelial progenitor cells. Hypertension 45:321–325

    Article  PubMed  CAS  Google Scholar 

  • Allan DS, Dube P, Roy J, Busque L, Roy DC (2007) Endothelial-like vascular progenitor cells (VPCs) from allogeneic and autologous donors: Mobilization features distinct from hematopoietic progenitors. Biol Blood Marrow Transplant 13:433–439

    Article  PubMed  CAS  Google Scholar 

  • Anagnostou A, Lee ES, Kessimian N, Levinson R, Steiner M (1990) Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci USA 87:5978–5982

    Article  PubMed  CAS  Google Scholar 

  • Asahara T, Masuda H, Takahashi T et al (1999) Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85:221–228

    PubMed  CAS  Google Scholar 

  • Asahara T, Murohara T, Sullivan A et al (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964–967

    Article  PubMed  CAS  Google Scholar 

  • Asosingh K, Aldred MA, Vasanji A et al (2008) Circulating angiogenic precursors in idiopathic pulmonary arterial hypertension. Am J Path 172:615–627

    Article  PubMed  CAS  Google Scholar 

  • Avall A, Hyller M, Swollin B, Bengtson J, Carlsson L, Bengtsson A (2002) Increased serum erythropoietin concentration after allogeneic compared with autologous blood transfusion. Transfusion 27:203–210

    CAS  Google Scholar 

  • Badorff C, Dimmeler S (2006) Neovascularization and cardiac repair by bone marrow-derived stem cells. Handb Exp Pharmacol 174:283–298

    Article  PubMed  Google Scholar 

  • Bahlmann FH, De Groot K, Spandau JM et al (2004) Erythropoietin regulates endothelial progenitor cells. Blood 103:921–926

    Article  PubMed  CAS  Google Scholar 

  • Bryder D, Rossi DJ, Weissman IL (2006) Hematopoietic stem cells: the paradigmatic tissue-specific stem cell. Am J Path 169:338–346

    Article  PubMed  CAS  Google Scholar 

  • Buechler C, Ritter M, Orsó E, Langmann T, Klucken J, Schmitz G (2000) Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli. J Leuk Biol 67:97–103

    CAS  Google Scholar 

  • Burger D, Lei M, Geoghegan-Morphet N, Lu X, Xenocostas A, Feng Q (2006) Erythropoietin protects cardiomycocytes from apoptosis via upregulation of endothelial nitric oxide synthase. Cardiovasc Res 72:51–59

    Article  PubMed  CAS  Google Scholar 

  • Calvi LM, Adams GB, Weibrecht KW et al (2003) Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425:841–846

    Article  PubMed  CAS  Google Scholar 

  • Carion A, Benboubker L, Herault O et al (2003) Stromal-derived factor 1 and matrix metalloproteinase 9 levels in bone marrow and peripheral blood of patients mobilized by granulocyte colony-stimulating factor and chemotherapy. Relationship with mobilizing capacity of haematopoietic progenitor cells. Br J Haematol 122:918–926

    Article  PubMed  CAS  Google Scholar 

  • Carlini RG, Reyes AA, Rothstein M (1995) Recombinant human erythropoietin stimulates angiogenesis in vitro. Kid Int 47:740–745

    Article  CAS  Google Scholar 

  • Ciccocioppo R, Bernardo ME, Sgarella A et al (2011) Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn’s disease. Gut, epub ahead of print, doi:10.1136/gut.2010.214841

    Google Scholar 

  • Critser PJ, Yoder MC (2010) Endothelial colony-forming cell role in neoangiogenesis and tissue repair. Curr Opin Organ Transplant 15:68–72

    Article  PubMed  Google Scholar 

  • Dimmeler S, Zeiher AM, Schneider MD (2005) Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest 115:572–583

    PubMed  CAS  Google Scholar 

  • Fernandez Pujol B, Lucibello FC, Gehling UM et al (2000) Endothelial-like cells derived from human CD14 positive monocytes. Differentiation 65:287–300

    Article  PubMed  CAS  Google Scholar 

  • Filip S, Vanasek J, Blaha MP, Vávrová J, Podzimek K (1999) The increase of the rate of hematopoietic recovery and clinical benefit of the erythropoietin (EPO) and granulocyte colony-stimulating factor (G-CSF) with peripheral blood progenitor cells (PBPC) after intensive cyclic chemotherapy in high-risk breast cancer patients. Neoplasma 46:166–172

    PubMed  CAS  Google Scholar 

  • Flynn A, Barry F, O’Brien T (2007) UC blood-derived mesenchymal stromal cells: an overview. Cytotherapy 9:717–726

    Article  PubMed  CAS  Google Scholar 

  • Friedrichs B, Tichelli A, Bacigalupo A et al (2010) Long-term outcome and late effects in patients transplanted with mobilised blood or bone marrow: a randomised trial. Lancet Oncol 11:331–338

    Article  PubMed  Google Scholar 

  • Ghani U, Shuaib A, Salam A et al (2005) Endothelial progenitor cells during cerebrovascular disease. Stroke 36:151–153

    Article  PubMed  Google Scholar 

  • Hart C, Grassinger J, Andreesen R, Hennemann B (2009) EPO in combination with G-CSF improves mobilization effectiveness after chemotherapy with ifosfamide, epirubicin and etoposide and reduces costs during mobilization and transplantation of autologous hematopoietic progenitor cells. Bone Marrow Transplant 43:197–206

    Article  PubMed  CAS  Google Scholar 

  • Hattori K, Heissig B, Tashiro K et al (2001) Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood 97:3354–3360

    Article  PubMed  CAS  Google Scholar 

  • Haynes SL, Wong JC, Torella F, Dalrymple K, Pilsworth L, McCollum CN (2001) The influence of homologous blood transfusion on immunity and clinical outcome in aortic surgery. Eur J Vasc Endovasc Surg 22:244–250

    Article  PubMed  CAS  Google Scholar 

  • Hébert PC, Wells G, Blajchman MA et al (1999) A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 340:409–417

    Article  PubMed  Google Scholar 

  • Heeschen C, Aicher A, Lehmann R et al (2003) Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 102:1340–1346

    Article  PubMed  CAS  Google Scholar 

  • Hill JM, Zalos G, Halcox JP et al (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348:593–600

    Article  PubMed  Google Scholar 

  • Hristov M, Weber C (2006) The therapeutic potential of progenitor cells in ischemic heart disease—past, present and future. Basic Res Card 101:1–7

    Article  Google Scholar 

  • Ingram DA, Mead LE, Moore DB, Woodard W, Fenoglio A, Yoder MC (2005) Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells. Blood 105:2783–2786

    Article  PubMed  CAS  Google Scholar 

  • Ingram DA, Mead LE, Tanaka H et al (2004) Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 104:2752–2760

    Article  PubMed  CAS  Google Scholar 

  • Iqbal T, Rajagopal T, Halpenny M et al (2008) Increased graft content of vascular progenitor cells is associated with reduced toxicity following autologous hematopoietic transplantation. Exp Hematol 36:506–12

    Article  PubMed  CAS  Google Scholar 

  • Jin F, Zh ai Q, Qiu L et al (2008) Degradation of BM SDF-1 by MMP-9: the role in G-CSF-induced hematopoietic stem/progenitor cell mobilization. Bone Marrow Transplant 42:581–588

    Article  PubMed  CAS  Google Scholar 

  • Kalka C, Masuda H, Takahashi T et al (2000) Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 97:3422–3427

    Article  PubMed  CAS  Google Scholar 

  • Karussis D, Karageorgiou C, Vaknin-Dembinsky A et al (2010) Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch Neurol 67:1187–1194

    Article  PubMed  Google Scholar 

  • Kasbia G, Al-Gahtani F, Tay J et al (2008) Reduced hemoglobin on day of peripheral blood progenitor cell collection is associated with low graft content of vascular progenitors and increased toxicity after autologous hematopoietic stem cell transplantation. Transfusion 48:2421–2428

    Article  PubMed  Google Scholar 

  • Kessinger A, Bishop MR, Jackson JD et al (1995) Erythropoietin for mobilization of circulating progenitor cells in patients with previously treated relapsed malignancies. Exp Hematol 23:609–612

    PubMed  CAS  Google Scholar 

  • Krantz SB (1991) Erythropoietin. Blood 77:419–434

    PubMed  CAS  Google Scholar 

  • Labonté L, Iqbal T, McDiarmid S, Bence-Bruckler I, Huebsch L, Allan DS (2008) Continuing erythropoietin during peripheral blood stem cell collection in myeloma: can it reduce toxicity of autologous transplants? Biol Blood Marrow Transplant 14:132–133

    Article  PubMed  Google Scholar 

  • Labonté L, Li Y, Yang L et al (2009) Increased plasma EPO and MIP-1α are associated with recruitment of vascular progenitors but not CD34(+) cells in autologous peripheral blood stem cell grafts. Exp Hematol 37:673–678

    Article  PubMed  Google Scholar 

  • Le Blanc K, Götherström C, Ringdén O, et al (2005) Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta Transplantation 79:1607–14

    Article  PubMed  Google Scholar 

  • Le Blanc K, Rasmusson I, Sundberg B et al (2004) Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363:1439–1441

    Article  PubMed  Google Scholar 

  • Lee HM, Wu W, Wysoczynski M et al (2009) Impaired mobilization of hematopoietic stem/­progenitor cells in C5-deficient mice supports the pivotal involvement of innate immunity in this process and reveals novel promobilization effects of granulocytes. Leukemia 23:2052–2062

    Article  PubMed  CAS  Google Scholar 

  • Levesque JP, Hendy J, Takamatsu Y, Simmons PJ, Bendall LJ (2003) Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest 111:187–196

    PubMed  CAS  Google Scholar 

  • Levesque JP, Takamatsu Y, Nilsson SK, Haylock DN, Simmons PJ (2001) Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor. Blood 98:1289–1297

    Article  PubMed  CAS  Google Scholar 

  • Lin Y, Weisdorf DJ, Solovey A, Hebbel RP (2000) Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 105:71–77

    Article  PubMed  CAS  Google Scholar 

  • Lin Y, Chang L, Solovey A, Healey JF, Lollar P, Hebbel RP (2002) Use of blood outgrowth endothelial cells for gene therapy for hemophilia A. Blood 99:457–462

    Article  PubMed  CAS  Google Scholar 

  • Liu K, Chen Y, Zeng Y, et al (2011) Coinfusion of mesenchymal stromal cells facilitates platelet recovery without increasing leukemia recurrence in haploidentical hematopoietic stem cell transplantation: a randomized, controlled clinical study. Stem Cells Dev 20:1679–1685

    Article  PubMed  CAS  Google Scholar 

  • Lyden D, Hattori K, Dias S et al (2001) Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nature Med 7:1194–1201

    Google Scholar 

  • Marino R, Martinez C, Boyd K, Dominici M, Hofmann TJ, Horwitz EM (2008) Transplantable marrow osteoprogenitors engraft in discrete saturable sites in the marrow microenvironment. Exp Hematol 36:360–368

    Article  PubMed  CAS  Google Scholar 

  • Mendez-Ferrer S, Michurina TV, Ferraro F et al (2010) Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466:829–836

    Article  PubMed  CAS  Google Scholar 

  • Micallef IN, Stiff PJ, DiPersio JF et al (2009) Successful stem cell remobilization using plerixafor (mozobil) plus granulocyte colony-stimulating factor in patients with non-Hodgkin lymphoma: results from the plerixafor NHL phase 3 study rescue protocol. Biol Blood Marrow Transplant 15:1578–1586

    Article  PubMed  CAS  Google Scholar 

  • Mikirova NA, Jackson JA, Hunninghake R et al (2009) Circulating endothelial progenitor cells: a new approach to anti-aging medicine? J Translat Med 7:106

    Article  Google Scholar 

  • Mittelman M, Zeidman A, Fradin Z, Magazanik A, Lewinski UH, Cohen A (1997) Recombinant human erythropoietin in the treatment of multiple myeloma-associated anemia. Acta Haematol 98:204–210

    Article  PubMed  CAS  Google Scholar 

  • Oh BJ, Kim K, Kim BJ et al (2010) Differences in donor CXCR4 expression levels are correlated with functional capacity and therapeutic outcome of angiogenic treatment with endothelial colony forming cells. Biochem Biophys Res Comm 398:627–633

    Article  PubMed  CAS  Google Scholar 

  • Olivieri A, Offidani M, Cantori I et al (1995) Addition of erythropoietin to granulocyte colony-stimulating factor after priming chemotherapy enhances hemopoietic progenitor mobilization. Bone Marrow Transplant 16:765–770

    PubMed  CAS  Google Scholar 

  • Peichev M, Naiyer AJ, Pereira D et al (2000) Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors. Blood 95:952–958

    PubMed  CAS  Google Scholar 

  • Pitchford SC, Furze RC, Jones CP, Wengner AM, Rankin SM (2009) Differential mobilization of subsets of progenitor cells from the bone marrow. Cell Stem Cell 4:62–72

    Article  PubMed  CAS  Google Scholar 

  • Prokopi M, Pula G, Mayr U et al (2009) Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures. Blood 114:723–732

    PubMed  CAS  Google Scholar 

  • Rabelink TJ, de Boer HC, de Koning EJ, van Zonneveld AJ (2004) Endothelial progenitor cells: more than an inflammatory response? Arterioscl Thromb Vasc Biol 24:834–838

    Article  PubMed  CAS  Google Scholar 

  • Ratajczak MZ, Wysoczynski M, Reca R et al (2008) A pivotal role of activation of complement cascade (CC) in mobilization of hematopoietic stem/progenitor cells (HSPC). Adv Exp Med Biol 632:47–60

    PubMed  CAS  Google Scholar 

  • Reinisch A, Hofmann NA, Obenauf AC et al (2009) Humanized large-scale expanded endothelial colony-forming cells function in vitro and in vivo. Blood 113:6716–6725

    Article  PubMed  CAS  Google Scholar 

  • Ribatti D, Vacca A, Nico B, Ria R, Dammacco F (2002) Cross-talk between hematopoiesis and angiogenesis signaling pathways. Curr Mol Med 2:537–547

    Article  PubMed  CAS  Google Scholar 

  • Rizzo JD, Lichtin AE, Woolf SH et al (2002) Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. Blood 100:2303–2320

    Article  PubMed  CAS  Google Scholar 

  • Schmeisser A, Garlichs CD, Zhang H et al (2001) Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel under angiogenic conditions. Cardiovasc Res 49:671–680

    Article  PubMed  CAS  Google Scholar 

  • Shepherd RM, Capoccia BJ, Devine SM et al (2006) Angiogenic cells can be readily mobilized and efficiently harvested from the blood following treatment with AMD3100. Blood 108:3662–3667

    Article  PubMed  CAS  Google Scholar 

  • Shintani S, Murohara T, Ikeda H et al (2001) Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103:2776–2779

    Article  PubMed  CAS  Google Scholar 

  • Shizuru JA, Negrin RS, Weissman IL (2005) Hematopoietic stem and progenitor cells: clinical and preclinical regeneration of the hematolymphoid system. Ann Rev Med 56:509–538

    Article  PubMed  CAS  Google Scholar 

  • Strehlow K, Werner N, Berweiler J et al (2003) Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation 107:3059–3065

    Article  PubMed  CAS  Google Scholar 

  • Urao N, Okigaki M, Yamada H et al (2006) Erythropoietin-mobilized endothelial progenitors enhance reendothelialization via Akt-endothelial nitric oxide synthase activation and prevent neointimal hyperplasia. Circ Res 98:1405–1413

    Article  PubMed  CAS  Google Scholar 

  • Vamvakas EC, Carven JH (1998) Allogeneic blood transfusion, hospital discharges, and length of hospitalization: a study of 487 consecutive patients undergoing colorectal cancer resection. Arch Pathol Lab Med 122:145–151

    PubMed  CAS  Google Scholar 

  • Verfaillie C (2002) Hematopoietic stem cells for transplantation. Nature Immunol 3:314–317

    Article  CAS  Google Scholar 

  • Walter DH, Zeiher AM, Dimmeler S (2004) Effects of statins on endothelium and their contribution to neovascularization by mobilization of endothelial progenitor cells. Coron Artery Dis 15:235–242

    Article  PubMed  Google Scholar 

  • Weber EW, Slappendel R, Prins MH, van der Schaaf DB, Durieux ME, Strümper D (2005a) Perioperative blood transfusions and delayed wound healing after hip replacement surgery: effects on duration of hospitalization. Anesth Analg 100:1416–1421

    Article  PubMed  Google Scholar 

  • Weber EW, Slappendel R, Hémon Y et al (2005b) Effects of epoetin alfa on blood transfusions and postoperative recovery in orthopaedic surgery: the European Epoetin Alfa Surgery Trial (EEST). Eur J Anaesthesiol 22:249–257

    Article  PubMed  CAS  Google Scholar 

  • Wesley RB 2nd, Meng X, Godin D, Galis ZS (1998) Extracellular matrix modulates macrophage functions characteristic to atheroma: collagen type I enhances acquisition of resident macrophage traits by human peripheral blood monocytes in vitro. Arterioscl Thromb Vascular Biol 18:432–440

    Article  CAS  Google Scholar 

  • Xenocostas A, Yee A, Wong CJ et al (2003) RBC transfusion requirements after allogeneic marrow transplantation: impact of the before-transplant Hb level on transfusion and early survival. Transfusion 43:373–382

    Article  PubMed  Google Scholar 

  • Yoder MC, Mead LE, Prater D et al (2007) Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109:1801–1809

    Article  PubMed  CAS  Google Scholar 

  • Yoon C-H, Hur J, Park K-W et al (2005) Synergistic Neovascularization by Mixed Transplantation of Early Endothelial Progenitor Cells and Late Outgrowth Endothelial Cells. Circulation 112:1618–1627

    Article  PubMed  Google Scholar 

  • Zhang ZG, Zhang L, Jiang Q, Chopp M (2002) Bone marrow-derived endothelial progenitor cells participate in cerebral neovascularization after focal cerebral ischemia in the adult mouse. Circ Res 90:284–288

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David S. Allan .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Labonté, L., Allan, D.S. (2012). Regenerative Potential of Blood Stem Cell Products Used in Hematopoietic Stem Cell Transplantation. In: Allan, D., Strunk, D. (eds) Regenerative Therapy Using Blood-Derived Stem Cells. Stem Cell Biology and Regenerative Medicine. Humana Press. https://doi.org/10.1007/978-1-61779-471-1_10

Download citation

Publish with us

Policies and ethics